Aspo Sells Its Leipurin Business to Lantmännen
Aspo Plc has taken a notable step in its strategic plan by signing an agreement to divest its Leipurin business to Lantmännen. This transaction is valued at approximately EUR 63 million, with an estimated cash consideration of around EUR 60 million to be finalized at closing. Such a move aligns with Aspo's vision to optimize its portfolio and focus on its core competencies.
Details of the Transaction
The divestment, pending regulatory approval, is anticipated to conclude in the first quarter of 2026. This decision is part of Aspo's broader strategy communicated at the Capital Markets Day held in mid-2024, outlining the creation of two distinct companies: Aspo Compounder, encompassing Telko and Leipurin, and Aspo Infra, which focuses on ESL Shipping.
Strengthening Financial Position
By selling the Leipurin segment, Aspo is poised to enhance its balance sheet, positioning itself for future growth investments particularly in its Telko business. Aspo aims to maximize shareholder value through strategic divestments like these.
CEO Comments on the Transition
CEO Rolf Jansson expressed pride in the transformation of Leipurin, emphasizing the successful transitions the company has undergone in recent years. He stated, “The divestment of the Leipurin business is the best way to implement Aspo’s strategy and value creation. With Lantmännen, Leipurin is set for systematic growth and development.”
Lantmännen's Strategic Objectives
Lantmännen, a leader in agriculture and food production in Northern Europe, sees the acquisition of Leipurin as a critical component of its goal to enhance the value chain in food ingredients. President and CEO Magnus Kagevik underscored the benefits of this acquisition, particularly in expanding their market reach and capabilities in the development of plant-based products.
Performance Insights
In the previous financial year, Leipurin reported net sales of EUR 133.1 million, with a comparable EBITA of EUR 4.9 million. The company has established a firm standing within the bakery and food service industries across Finland, Sweden, and the Baltic countries, employing around 160 individuals.
Operational Structure Post-Acquisition
Post-sale, Leipurin will remain a distinct entity within Lantmännen's Energy Division, which incorporates other food ingredient operations, including plant-based proteins. This setup is expected to foster further innovation and customer collaboration.
Future Outlook for Aspo and Leipurin
Aspo will categorize the Leipurin business as discontinued operations starting from the third quarter of 2025, projecting a sales gain of approximately EUR 16 million from this divestment. Despite this change, Aspo maintains that its financial guidance for 2025 remains unaltered, with expected comparable EBITA ranging from EUR 35 to 45 million.
Lantmännen’s Leadership in Agriculture
Lantmännen continues to solidify its position as an agricultural cooperative owned by 17,000 farmers in Sweden, with over 12,000 employees and a robust annual turnover of SEK 70 billion across 20 countries. The company emphasizes sustainable practices in its operations, aiming for continuous improvement in agricultural productivity and food quality.
Aspo's Commitment to Sustainable Development
Aspo, founded in 1929, is committed to sustainable value creation across its operations in shipping and various industries. It remains dedicated to providing innovative solutions and fostering long-term relationships with customers throughout Europe and parts of Asia. Aspo is listed on Nasdaq Helsinki, reflecting its commitment to transparency and investor engagement.
Frequently Asked Questions
What prompted the sale of Leipurin by Aspo?
Aspo's decision to divest Leipurin aligns with its strategic plan to focus on core segments and strengthen its financial position for future investments.
How much was the Leipurin business sold for?
The Leipurin business was sold for an enterprise value of EUR 63 million, with approximately EUR 60 million expected to be received in cash at closing.
What will happen to the Leipurin business after the sale?
Following the sale, Leipurin will operate as a separate business within Lantmännen's Energy Division, focusing on food ingredients and innovation.
What are the expected financial impacts of the sale for Aspo?
Aspo anticipates a sales gain of about EUR 16 million from the transaction, but maintains its previous financial guidance for 2025.
How does the sale fit into Aspo's broader strategy?
This divestment is part of Aspo's plan to enhance shareholder value and execute a vision of forming two independent companies focused on distinct markets and growth opportunities.
